Dear Sabine: The increased discharge might be related to the "stronger" birth control pill (BCP) you are currently taking. The estrogen component in a BCP is usually responsible for increased vaginal wetness. Thus if your current BCP has more estrogen than your former BCP, that might account for the increased discharge. As always, the discharge should be checked under the microscope to rule out any sign of infection.
There are a couple of schools of thought about how to assess for menopause in a BCP user. Some women will start to have noticeable hot flashes by the day 5-7 of the placebo pills as the estrogen effect from the BCP wears off. Some GYNs will draw an FSH blood level on placebo day 7 to see if the FSH is markedly elevated. Others will just leave the woman on the BCP until she is 50 or 51 then begin checking an FSH yearly.
There was one study, published in the journal
Contraception, which found that it may take longer than 5-7 days to get an accurate FSH level in a 50 year old BCP user. I could not relocate that study so here is another, older citation from teh National Library of Medicine site:
Fertil Steril. 1996 Jul;66(1):101-4.
Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD.
Source
University of Pittsburgh School of Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Hospital, Pennsylvania 15213-3180, USA.
OBJECTIVE:
To evaluate laboratory criteria for menopause in women talking oral contraceptives (OC).
DESIGN:
Prospective, uncontrolled pilot study.
SETTING:
San Francisco General Hospital, San Francisco, California, and Magee-Womens Hospital, Pittsburgh, Pennsylvania.
Fourteen menopausal women received triphasic 35 micrograms ethinyl E2 and 180-215-250 micrograms norgestimate, and 14 menopausal women received monophasic 30 micrograms ethinyl E2-150 micrograms desogestrel.
MAIN OUTCOME MEASURES:
Serum FSH, LH, and E2 levels were evaluated on days 14 and 28 (day 7 of the pill-free interval) of the third cycle of pills.
RESULTS:
Twelve women in each group completed the study. Fifteen (62.5%) subjects still had a serum FSH < 30 mIU/mL (30 IU/L) on the 7th day of the pill-free interval of the third pill package. All subjects had a serum FSH:LH ratio > 1 and 20 of 21 (95%) subjects had E2 < 20 pg/mL (73 pmol/L) at the end of the pill-free interval of the third cycle.
CONCLUSIONS:
.... These findings suggest that the mid-cycle FSH:LH ratio and measuring FSH on the seventh day of the pill-free interval are not reliable indicators of menopause. Instead, a serum FSH:LH ratio of 1 or an estradiol level of 20 pg/ml on the seventh day of the pill-free interval may be a more reliable indicator of menopause in women using OCs in their later reproductive years.
Bottom line, you should see what your GYN uses as the criteria for diagnosing menopause in their older BCP patients.
Yours,
Jane